India, Sept. 1 -- The German market is modestly higher on Monday, as a U.S. appeals court ruling that many of Donald Trump's tariffs were illegal. Healthcare stocks are finding support after Danish pharma company Novo Nordisk's weight-loss drug Wegovy offered better heart-protective benefits than rival treatments from U.S.-based Eli Lilly.
The 7-4 ruling by the U.S. Court of Appeals for the Federal Circuit affirmed a lower court's finding that Trump had exceeded his authority in tapping emergency economic powers to impose wide-ranging duties.
At the same time, the judges allowed the tariffs to stay in place through mid-October, giving Trump time to take the fight to the Supreme Court.
Dutch pharma major Novo Nodisk said Wegovy cut the ri...